Methylation of MGMT, DAPK,THBS1 and RIZ1 genes in hepatocellular carcinoma
Bo Qian
Abstract
Bo Qian
Abstract
Objective To study the methylation of MGMT, DAPK, THBS1 and RIZ1 genes in hepatocellular carcinoma. MethodsMethylation specific PCR was adopted to investigate the promoter methylation of these genes in 40 cases of HCC and 2 normal liver tissues. The relationship between the frequency of methylation of the genes and clinical data was analyzed. ResultsNormal liver has no genes methylation. In patients with HCC, the frequency of methylation in MGMT, DAPK, THBS1 and RIZ1 was 15%, 77 5%, 37 5% and 30%, respectively. Methylation of at least one gene could be detected in 87 5% HCC patients. In the non tumor liver tissues, the frequency of methylation in MGMT, DAPK, THBS1 and RIZ1 were detected in 5%, 77 5%, 27 5% and 5%, respectively. Methylation of RIZ1 was more frequent in HCC than in non tumor liver tissues (χ 2=8 658, P 0 05). HCC patients with methylation of two genes were younger than those with only one ( t =2 389, P 0 05). HCC patients with methylation of THBS1 were younger than those without ( t =3 047, P 0 05). ConclusionsMethylation of multiple genes is a common event in HCC.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the methylation of MGMT, DAPK, THBS1 and RIZ1 genes in hepatocellular carcinoma. MethodsMethylation specific PCR was adopted to investigate the promoter methylation of these genes in 40 cases of HCC and 2 normal liver tissues. The relationship between the frequency of methylation of the genes and clinical data was analyzed. ResultsNormal liver has no genes methylation. In patients with HCC, the frequency of methylation in MGMT, DAPK, THBS1 and RIZ1 was 15%, 77 5%, 37 5% and 30%, respectively. Methylation of at least one gene could be detected in 87 5% HCC patients. In the non tumor liver tissues, the frequency of methylation in MGMT, DAPK, THBS1 and RIZ1 were detected in 5%, 77 5%, 27 5% and 5%, respectively. Methylation of RIZ1 was more frequent in HCC than in non tumor liver tissues (χ 2=8 658, P 0 05). HCC patients with methylation of two genes were younger than those with only one ( t =2 389, P 0 05). HCC patients with methylation of THBS1 were younger than those without ( t =3 047, P 0 05). ConclusionsMethylation of multiple genes is a common event in HCC.
Key concepts: Methylation, Hepatocellular carcinoma, Medicine, Gene, Cancer research, DNA methylation, Carcinoma, Internal medicine